PRESS RELEASE

​

I am delighted to announce the results of the preliminary study into the effects of McLoughlin Scar Tissue Release® (MSTR®) on Caesarean Section scars.  The research project was conducted at The Newcastle Clinic, Newcastle, UK on June 15th, 2019 with Consultant Radiologist Dr. Peddada Raju.

​

A General Electric (GE) Soniq S8 ultrasound scanner was used for the test. Three test subjects with C-sections were pre-scanned and images recorded. Size and depth of scar tissue were also recorded and the amount of both surrounding and within the scar was also imaged.

​

MSTR® work was then applied for a total of 15 minutes per subject only, as a single treatment.  Immediately afterwards a post-treatment ultrasound scan was then conducted by Dr. Raju.

​

All three subjects were shown to have decreased scar tissue in the post-treatment scan. One example of improvement was a scar that was measured at 31.5mm pre-treatment. The scar was re-measured at just 18.1mm post-treatment.

​

Another example was that of a longitudinal scar reducing in size from 22.7mm pre-treatment to just 10.4mm post-treatment.  An increase in vascularity was noted not only in the surrounding tissue but also actually through the scar. Interestingly, no vascularity was present in the pre-scan of the same area.

​

This confirms what has always been stated: MSTR® helps open the densely bound collagen fibres that makeup scar tissue to allow increased blood flow into the area once again.

​

This preliminary success has now kick-started a larger study that will be undertaken at ‘The Newcastle’ later in 2019.  You can read more about the MSTR® Research Project here:  https://www.mcloughlin-scar-release.com/research/

​

This means that you can have even more confidence in MSTR® work now that it is an evidence-based method of scar tissue treatment.